Edwards Lifesciences Corp Quarterly Other Assets, Current in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Edwards Lifesciences Corp quarterly Other Assets, Current history and growth rate from Q2 2010 to Q3 2024.
  • Edwards Lifesciences Corp Other Assets, Current for the quarter ending September 30, 2024 was $231M, a 2.04% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $231M -$4.8M -2.04% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $252M +$34.7M +16% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $251M +$60.3M +31.7% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $225M +$29M +14.8% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $236M -$31.8M -11.9% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $217M -$31.4M -12.6% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $190M -$44.2M -18.8% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $196M -$41.2M -17.4% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $268M +$25.7M +10.6% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $249M +$15.5M +6.64% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $235M +$5.4M +2.36% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $237M +$28.9M +13.9% Dec 31, 2021 10-K 2023-02-13
Q3 2021 $242M +$70.4M +41.1% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $233M +$67.1M +40.4% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $229M +$65.4M +40% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $208M +$40.2M +23.9% Dec 31, 2020 10-K 2022-02-14
Q3 2020 $172M +$27.1M +18.8% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 $166M +$36M +27.7% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 $164M +$22.2M +15.7% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $168M +$36.2M +27.5% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $144M -$6M -3.99% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $130M -$6.9M -5.03% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $142M +$22.6M +19% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $132M +$14.9M +12.7% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $150M +$53M +54.4% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $137M +$41.9M +44% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $119M +$13.3M +12.6% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $117M +$5.1M +4.56% Dec 31, 2017 10-K 2019-02-15
Q3 2017 $97.4M +$31.3M +47.4% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $95.2M +$13.7M +16.8% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $106M +$32M +43.5% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $112M +$45.4M +68.4% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $66.1M -$30.5M -31.6% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $81.5M -$30.9M -27.5% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $73.6M -$64.8M -46.8% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $66.4M -$55.3M -45.4% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $96.6M +$7M +7.81% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $112M +$52.1M +86.4% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $138M +$61.2M +79.3% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $122M +$49.9M +69.5% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $89.6M +$6.4M +7.69% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $60.3M -$37.4M -38.3% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $77.2M -$29.3M -27.5% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $71.8M +$14.8M +26% Dec 31, 2013 10-K 2015-02-20
Q3 2013 $83.2M +$13.9M +20.1% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $97.7M +$2.2M +2.3% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $107M +$16.3M +18.1% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $57M -$100K -0.18% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $69.3M +$1.5M +2.21% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $95.5M +$42.2M +79.2% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $90.2M +$44.3M +96.5% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $57.1M -$5.6M -8.93% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $67.8M +$41.2M +155% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $53.3M +$17.8M +50.1% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $45.9M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $62.7M Dec 31, 2010 10-K 2012-02-27
Q3 2010 $26.6M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $35.5M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.